Welcome to our dedicated page for Blue Biofuels SEC filings (Ticker: BIOF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Blue Biofuels, Inc. (BIOF) SEC filings page on Stock Titan is intended to present the company’s regulatory disclosures alongside AI-generated context. While no specific filings are listed in the data provided here, investors typically look to SEC reports for details on a company’s technology, risks, financing, and strategic plans. For a company like Blue Biofuels, which focuses on cellulosic biofuels through its patented Cellulose-to-Sugar (CTS) technology and licensed Vertimass technology, formal filings can complement the information shared in press releases.
When available, annual reports (Form 10-K) and quarterly reports (Form 10-Q) can provide narrative and financial discussion of Blue Biofuels’ CTS process, its use of biomass feedstocks such as king grass, sugarcane bagasse, and corn stover, and its efforts to scale pilot operations into commercial facilities. Current reports (Form 8-K) may discuss events like government grants, land acquisition for a Frostproof, Florida production site, joint venture developments with Vertimass, or changes in auditors, all of which the company has referenced in public announcements.
On Stock Titan, AI tools are designed to summarize lengthy filings, highlight key sections, and clarify technical or legal language. When Blue Biofuels filings are available, these tools can help readers quickly locate disclosures related to its CTS patents, VertiBlue Fuels joint venture, government support such as Department of Energy grants, and any reported risks associated with scaling cellulosic ethanol and sustainable aviation fuel production.
In addition, forms related to insider activity, such as Form 4 when present, can be used to review reported transactions by officers, directors, or significant shareholders. Together, these documents and AI explanations can provide a structured view of how Blue Biofuels describes its business, technology, and obligations in its official SEC reporting.
Blue Biofuels, Inc. reported a net loss of $2.87 million for the year ended December 31, 2025, compared with a $1.42 million loss in 2024, and again generated no revenue from its core operations. Results were helped by $865,000 of U.S. Department of Energy grant income, but the company still recorded an accumulated deficit of $60.13 million.
Blue Biofuels advanced its patented Cellulose-to-Sugar (CTS) technology, completed pilot-plant upscaling work, and formed a 50-50 joint venture with Vertimass to target sustainable aviation fuel production in Florida. However, it ended 2025 with only $65,200 in cash, a working capital deficit of $2.91 million, negative equity of $3.71 million, and its auditors highlighted substantial doubt about its ability to continue as a going concern. Management estimates it will need roughly $90 million in project financing to fund its share of the VertiBlue Fuels joint venture and move into commercial production.
Blue Biofuels (BIOF) filed its Q3 2025 10‑Q, reporting no revenue and a net loss of $422,547 for the quarter and $1,587,132 for the nine months ended September 30, 2025. The company recognized $420,030 in DOE grant income in the quarter and $865,000 year‑to‑date, which partially offset operating expenses.
Cash was $95,194 and total liabilities were $4,543,537 as of September 30, 2025. Stockholders’ deficit widened to $3,057,336. Management disclosed “substantial doubt” about the company’s ability to continue as a going concern due to recurring losses, limited liquidity, and the need for additional financing.
During 2025 to date, the company raised cash through equity and debt: $435,000 from private placements of common stock and warrants, $185,000 of related‑party notes, and $6,250 from warrant exercises. Shares outstanding were 315,723,332 as of October 23, 2025; this is a baseline figure, not an amount being offered.